Literature DB >> 18511947

Strong association of de novo copy number mutations with sporadic schizophrenia.

Bin Xu1, J Louw Roos, Shawn Levy, E J van Rensburg, Joseph A Gogos, Maria Karayiorgou.   

Abstract

Schizophrenia is an etiologically heterogeneous psychiatric disease, which exists in familial and nonfamilial (sporadic) forms. Here, we examine the possibility that rare de novo copy number (CN) mutations with relatively high penetrance contribute to the genetic component of schizophrenia. We carried out a whole-genome scan and implemented a number of steps for finding and confirming CN mutations. Confirmed de novo mutations were significantly associated with schizophrenia (P = 0.00078) and were collectively approximately 8 times more frequent in sporadic (but not familial) cases with schizophrenia than in unaffected controls. In comparison, rare inherited CN mutations were only modestly enriched in sporadic cases. Our results suggest that rare de novo germline mutations contribute to schizophrenia vulnerability in sporadic cases and that rare genetic lesions at many different loci can account, at least in part, for the genetic heterogeneity of this disease.

Entities:  

Mesh:

Year:  2008        PMID: 18511947     DOI: 10.1038/ng.162

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  373 in total

1.  Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.

Authors:  Thomas V Fernandez; Stephan J Sanders; Ilana R Yurkiewicz; A Gulhan Ercan-Sencicek; Young-Shin Kim; Daniel O Fishman; Melanie J Raubeson; Youeun Song; Katsuhito Yasuno; Winson S C Ho; Kaya Bilguvar; Joseph Glessner; Su Hee Chu; James F Leckman; Robert A King; Donald L Gilbert; Gary A Heiman; Jay A Tischfield; Pieter J Hoekstra; Bernie Devlin; Hakon Hakonarson; Shrikant M Mane; Murat Günel; Matthew W State
Journal:  Biol Psychiatry       Date:  2011-12-14       Impact factor: 13.382

Review 2.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

3.  Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Authors:  Liam J Drew; Kimberly L Stark; Karine Fénelon; Maria Karayiorgou; Amy B Macdermott; Joseph A Gogos
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

Review 4.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

5.  Rare CNVs and tag SNPs at 15q11.2 are associated with schizophrenia in the Han Chinese population.

Authors:  Qian Zhao; Tao Li; XinZhi Zhao; Ke Huang; Ti Wang; ZhiQiang Li; Jue Ji; Zhen Zeng; Zhao Zhang; Kan Li; GuoYin Feng; David St Clair; Lin He; YongYong Shi
Journal:  Schizophr Bull       Date:  2012-02-08       Impact factor: 9.306

6.  Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing.

Authors:  Andy Itsara; Lisenka E L M Vissers; Karyn Meltz Steinberg; Kevin J Meyer; Michael C Zody; David A Koolen; Joep de Ligt; Edwin Cuppen; Carl Baker; Choli Lee; Tina A Graves; Richard K Wilson; Robert B Jenkins; Joris A Veltman; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

Review 7.  Genetic contributions to behavioural diversity at the gene-environment interface.

Authors:  Andres Bendesky; Cornelia I Bargmann
Journal:  Nat Rev Genet       Date:  2011-11-08       Impact factor: 53.242

8.  Rbfox Splicing Factors Promote Neuronal Maturation and Axon Initial Segment Assembly.

Authors:  Martin Jacko; Sebastien M Weyn-Vanhentenryck; John W Smerdon; Rui Yan; Huijuan Feng; Damian J Williams; Joy Pai; Ke Xu; Hynek Wichterle; Chaolin Zhang
Journal:  Neuron       Date:  2018-02-01       Impact factor: 17.173

Review 9.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

Review 10.  The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research.

Authors:  Conrad Iyegbe; Desmond Campbell; Amy Butler; Olesya Ajnakina; Pak Sham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-17       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.